Sort
30,917 grants matching “tumor microenvironment”
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$505,472Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Targeting bidirectional signaling in lung stroma and cancer cells
$505,460Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA
Pathways that regulate basal and metastatic phenotypes in triple negative breast cancers
$505,444Teresa L Wood · Rbhs-New Jersey Medical School · R01 · FY2020 · CA
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$505,327Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2025 · CA
THE EFFECT OF TUMOR MICROENVIRONMENT ON METASTASIS
$505,327Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Protein Kinase Signaling in the Genotoxic Stress Response
$505,321Michael B Yaffe · Massachusetts Institute Of Technology · R35 · FY2024 · ES
Collagen structural changes as an early biomarker for breast carcinoma
$505,303Patricia J Keely · University Of Wisconsin-Madison · R01 · FY2015 · CA
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$505,275Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2017 · CA
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
$505,216Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
$505,216Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
$505,159Weizhou Zhang · University Of Florida · R01 · FY2023 · CA
Gut Microbiome, Antibiotic Use & Colon Cancer Recurrence
$505,130Veronika Fedirko · Emory University · R01 · FY2018 · CA
The role of multi-cellular aggregates vs. individual tumor cells in metastasis of high-grade serous ovarian cancer
$505,123Pamela K Kreeger · University Of Wisconsin-Madison · R01 · FY2020 · CA
KSHV Replication and Trained Immunity
$505,056Yoshihiro Izumiya · University Of California At Davis · R01 · FY2025 · DE
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$505,053Steven Mark Albelda · University Of Pennsylvania · P01 · FY2022 · CA
Preclinical Electron Paramagnetic Resonance Tumor Imager
$505,011Gareth R Eaton · University Of Denver (Colorado Seminary) · R01 · FY2024 · CA
Myofibroblasts in Gastrointestinal Cancers
$505,000Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2011 · CA
Delineation of Leukocyte Biomarkers for Human Breast Cancer Outcome
$504,942Lisa M Coussens · Oregon Health & Science University · U54 · FY2014 · CA
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes
$504,942Lisa M Coussens · Oregon Health & Science University · U54 · FY2014 · CA
How does EGFR facilitate the constitutive activation of STAT3 in tumors?
$504,935George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · CA
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$504,865David H Sherr · Boston University Medical Campus · R01 · FY2023 · ES
A New Paradigm to Prevent and Treat Micrometastases
$504,838Timothy P Cripe · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Vermont Screening Process Documentation Unit
$504,826Brian L Sprague · University Of Vermont & St Agric College · U54 · FY2014 · CA
NF-kB Regulation of the Muscle Microenvironment in Cancer Cachexia
$504,804Denis C Guttridge · Medical University Of South Carolina · R01 · FY2023 · AR
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)
$504,780Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2012 · CA